Cell BioEngines Enters Agreement with Miltenyi Bioindustry
Cell BioEngines to Leverage Miltenyi’s Expertise and Proven Platforms to Develop and Manufacture Hematopoietic Stem Cell Transplantation (HSCT) Product...
Source: globenewswire.com
📰 Stem Cell Based Therapy News
Stem Cell Based Therapy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stem Cell Based Therapy. Real-time updates on events, politics, business and more.
Cell BioEngines Licenses Patent for Allogeneic
Small molecule-mediated expansion of engraftable cord-blood derived hematopoietic stem cells (HSC) to address donor availability for allogenic...
Source: globenewswire.com
New stem cell-based therapy can repair damaged heart
During preclinical trials, the precursor cells were injected into the area of the heart damaged by myocardial infarction, where they were able to.health. healthcare. wellness. well-being. stem cell-based therapy. damaged heart. fitness
Karl Tryggvason Lynn Yap Nanyang Technological University Regenerative Medicine Assistant Professor Lee Kong Chian School
Source: onmanorama.com
Global Acellular Therapy Market Report 2022: Cell Therapy vs. Cell-Free Therapy, Clinical Trial Analysis, Competitive Landscape
/PRNewswire/ -- The "Global Acellular Therapy Market - Strategies and Applications: Focus on Application, Pipeline, and Competitive Landscape" report has been...
South Korea Laura Wood Company Overview Organicell Regenerative Medicine Inc Codiak Biosciences Inc Office Hours Call
Source: prnewswire.com
A new international consortium to promote Stem Cell-Based Therapy for Huntington's disease
The Stem Cells for Huntington’s Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington’s Disease. The entity, made up of twenty-eight renowned researchers from ten countries, has been officially presented in a recent publication in the J ournal of Huntington’s Disease. The main goals of SC4HD researchers are to work together with the HD community, develop criteria and guidance an...
Comunidad Autonoma De Cataluna Validation Center University Of Barcelona Pii Sunyer Biomedical Research Institute Biomedical Research Networking Center On Neurodegenerative Diseases Department Of Biomedicine
Source: ub.edu
Procyon Technologies LLC and Novo Nordisk A/S to Collaborate on the Development of a Stem-Cell Based Therapy for Type 1 Diabetes | More News
Hits: 845 TUCSON, AZ, USA I December 8, 2020 I Procyon Technologies LLC today announced that it has entered into an exclusive research collaboration and license agreement with Novo Nordisk A/S to develop an implantable cell encapsulation device to be used in Novo Nordisks development of a novel therapy for Type 1 diabetes. The collaboration brings together Procyon Technologies expertise with development of oxygen enabled implantable cell encapsulation devices and Novo Nordisks expertise in ...
Source: pipelinereview.com